CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这是一项由美国国立卫生研究院赞助的多中心1-2期试验，比较了之前接种过1级疫苗的人和服用安慰剂的2级禽流感疫苗的安全性和免疫反应。受试者被随机接受低剂量(15g)或高剂量(90g)的疫苗。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an NIH-sponsored multi-center phase 1-2 trial comparing the safety and immune responses of a clade 2 avian influenza vaccine in prior recipients of a clade 1 vaccine versus placebo. Subject are randomized to get either a low dose (15 ¿g) or a high dose (90 ¿g) of the vaccine.